logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10028909 B1

PDFFull Text
Date of Patent:
Jul. 24, 2018

Filed:

Feb. 21, 2017

Rapidly dispersible dosage form of oxcarbazepine

Applicant:

Aprecia Pharmaceuticals Company, Langhorne, PA (US);

Inventors:

Jules Jacob, Yardley, PA (US);

Kelly Caputo, Langhorne, PA (US);

Micael Guillot, Lansdale, PA (US);

Kenneth J. Sultzbaugh, Bridgewater, NJ (US);

Thomas G. West, Lawrenceville, NJ (US);

Assignee:

APRECIA PHARMACEUTICALS LLC, Blue Ash, OH (US);

Attorneys:

Innovar, L.L.C.

Rick Matos

Primary Examiner:

Ernst V Arnold

Int. Cl.
CPC ...
A61K 9/16 (2006.01); A61K 9/00 (2006.01); A61K 31/55 (2006.01); A61K 9/20 (2006.01); A61K 9/70 (2006.01); B33Y 10/00 (2015.01); B33Y 70/00 (2015.01); B33Y 80/00 (2015.01); B29C 64/165 (2017.01); B29K 105/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0056 (2013.01); A61K 9/1611 (2013.01); A61K 9/1617 (2013.01); A61K 9/1623 (2013.01); A61K 9/1635 (2013.01); A61K 9/1652 (2013.01); A61K 9/1694 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/7007 (2013.01); A61K 31/55 (2013.01); B29C 64/165 (2017.08); B33Y 10/00 (2014.12); B33Y 70/00 (2014.12); B33Y 80/00 (2014.12); B29K 2105/0035 (2013.01); B29K 2105/0058 (2013.01); B29K 2105/251 (2013.01);
Abstract

A high dose orodispersible dosage form of oxcarbazepine is provided. Drug-containing particles of oxcarbazepine are included within a porous bound matrix. The dosage form disperses in saliva or water in less than 15 sec and it has sufficient hardness to withstand handling and storage. It can be used to treat diseases or disorders that are therapeutically responsive to oxcarbazepine or a derivative thereof.

Find Patent Forward Citations

Jacob, Jules. (2018). Rapidly dispersible dosage form of oxcarbazepine (U.S. Patent No. 10028909). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10028909

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…